Press release
Acne Vulgaris Market Poised for Growth as Emerging Therapies Reshape Treatment Landscape Through 2034, Reports DelveInsight
Acne Vulgaris Market
Gain exclusive access to in-depth market dynamics, emerging therapies, and pipeline advancements in the Acne Vulgaris space. Download the full report here: Acne Vulgaris Market Size - https://www.delveinsight.com/sample-request/acne-vulgaris-av-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Highlights from the Acne Vulgaris Market Report
• In September 2025, Vanda Pharmaceuticals launched a Phase II, multicenter, randomized, double-blind, placebo-controlled clinical study to assess the safety, efficacy, and pharmacokinetics of imsidolimab in both adolescent and adult Acne Vulgaris patients. The trial also investigates the immune response to the drug.
• Approximately 140.2 million prevalent cases of Acne Vulgaris were reported across the 7MM in 2023, with nearly 69.5 million cases in the US alone. These figures are projected to grow steadily throughout the forecast period.
• Gender-based analysis indicates that females accounted for 63% of diagnosed prevalent cases across the 7MM.
• By severity, moderate acne represented the largest diagnosed population (45%) in 2023, while severe cases comprised about 10%.
• Leading Acne Vulgaris companies include Galderma Labs, Ortho Dermatologics, Bausch Health, Timber Pharmaceuticals, BioPharmX, Botanix Pharmaceuticals, Kintor Pharma, among others.
• Key Acne Vulgaris emerging therapies include B244, SB204, DMT310, BTX 1503, and several additional candidates.
Stay competitive with actionable insights into market performance, therapeutic advancements, and strategic opportunities. Access further details here: Acne Vulgaris Treatment Market Size - https://www.delveinsight.com/sample-request/acne-vulgaris-av-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acne Vulgaris Epidemiology Segmentation Covered in the Report (7MM)
• Total Acne Vulgaris Prevalent Cases
• Acne Vulgaris Diagnosed Prevalent Cases
• Acne Vulgaris Severity-Based Diagnosed Cases
• Gender-Specific Diagnosed Cases
• Age-Specific Diagnosed Cases
Download the report to explore the key factors influencing epidemiology trends: Acne Vulgaris Prevalence - https://www.delveinsight.com/sample-request/acne-vulgaris-av-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Marketed Therapies for Acne Vulgaris
AKLIEF (Trifarotene) - Galderma S.A.
A fourth-generation topical retinoid approved by the FDA for patients aged ≥9 years. Trifarotene selectively targets RAR-γ receptors-the most abundant retinoic acid receptors in the skin-offering enhanced specificity and improved outcomes. It demonstrates early and sustained efficacy across facial and truncal acne, with mild, manageable side effects such as irritation and pruritus.
AMZEEQ (Minocycline) - Journey Medical Corp./Vyne Therapeutics
Approved in 2019, AMZEEQ is a topical foam formulation of minocycline for moderate-to-severe inflammatory acne in patients aged ≥9 years. Leveraging Foamix's MST technology, the foam provides targeted delivery with broad dermatological utility, including use in rosacea.
ARAZLO (Tazarotene) - Bausch Health/Ortho Dermatologics
A 0.045% tazarotene lotion designed to minimize irritation through an optimized polymeric emulsion technology and the inclusion of moisturizing agents. Approved for patients aged ≥9 years, it offers effective acne management with an improved tolerability profile.
Promising Acne Vulgaris Emerging Therapies
SB204 - Pelthos Therapeutics
A nitric oxide-based topical monotherapy targeting the multifactorial nature of acne through anti-inflammatory and antibacterial mechanisms.
B244 - AOBiome
A novel microbiome-restoring topical treatment containing Nitrosomonas eutropha, designed to modulate inflammation and rebalance the skin ecosystem.
DMT310 - Dermata Therapeutics
A first-in-class biological treatment derived from Spongilla lacustris, targeting IL-17 mediated inflammation. Currently in Phase III development for Acne Vulgaris.
Explore next-generation treatment options and pipeline updates: Acne Vulgaris Market Drivers and Barriers - https://www.delveinsight.com/sample-request/acne-vulgaris-av-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acne Vulgaris Market Outlook
Managing Acne Vulgaris requires a multi-tiered approach combining lifestyle modifications, topical regimens, and systemic therapies. Market growth is propelled by increasing disease prevalence, rising consumer focus on skincare, and expanding therapeutic alternatives. Current treatment categories include keratolytics (salicylic acid, azelaic acid), oral antibiotics (tetracycline, doxycycline), retinoids (isotretinoin), and hormonal agents (spironolactone).
Scope of the Acne Vulgaris Market Report
• Geographies Covered: 7MM
• Study Period: 2020-2034
• Key Acne Vulgaris Companies: Galderma Labs, Ortho Dermatologics, Bausch Health, Timber Pharmaceuticals, BioPharmX, Botanix Pharmaceuticals, Kintor Pharma, and others
• Key Acne Vulgaris Therapies: B244, SB204, DMT310, BTX 1503, among others
• Assessment Areas: Marketed & Emerging Therapies, Market Dynamics, Unmet Needs, KOL Insights, Reimbursement Landscape
Learn more about ongoing trials, competitive intelligence, and evolving market opportunities: Acne Vulgaris Clinical Trials Analysis - https://www.delveinsight.com/sample-request/acne-vulgaris-av-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Vulgaris Market Poised for Growth as Emerging Therapies Reshape Treatment Landscape Through 2034, Reports DelveInsight here
News-ID: 4297324 • Views: …
More Releases from DelveInsight Business Research
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets.
Explore the…
Myopic Macular Degeneration market across the 7MM is projected to reach USD 837 …
In 2022, the Myopic Macular Degeneration market across the 7MM was valued at approximately USD 734 million, largely driven by anti-VEGF therapies and standard care. The Myopic Macular Degeneration market is expected to grow gradually through 2034, constrained by a limited pipeline of emerging treatments. Japan accounts for the largest share of diagnosed cases (49%), followed by the United States (27%). Females are disproportionately affected across the 7MM, potentially due…
Netherton syndrome market across the 7MM was valued at approximately USD 25 mill …
The Netherton syndrome market is projected to grow at a 7% CAGR from 2025 to 2034, driven by key regions including the US, EU4, the UK, and Japan. In 2024, around 3,500 diagnosed prevalent cases were reported across the 7MM. Market expansion is primarily supported by advancing diagnostic capabilities, increasing disease awareness, rising diagnosis rates, and a strengthening clinical pipeline led by companies such as Azitra (ATR-12), Quoin Pharmaceuticals (QRX003),…
Sandhoff Disease Pipeline Analysis Highlights Emerging Therapies and Active Indu …
DelveInsight's "Sandhoff Disease Pipeline Insight 2025" report delivers an extensive overview of the Sandhoff Disease pipeline landscape, featuring insights on more than 5 companies and over 5 pipeline candidates. The report analyzes both clinical- and non-clinical-stage drug candidates, offering detailed profiles of Sandhoff Disease pipeline products. It also evaluates emerging therapeutics based on product category, development stage, route of administration, and molecular classification, while additionally highlighting inactive or discontinued pipeline…
More Releases for Acne
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during the forecast period, 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Growing Acne Incidences Benefiting Global Anti-Acne Dermal Patch Market Developm …
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of…
Rising Cases of Acne Boosting Professional Acne Treatment Market Growth
Factor such as the rising cases of acne, surging adoption of acne treatments, growing healthcare spending, increasing disposable income, sedentary lifestyle, strong product pipeline, and mounting number of research programs are expected to propel the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market size is expected to reach $13,124.5 million by 2030 from $6,298.9 million in 2020. Moreover, the market is…
Global Market Study on Acne Treatment Inflammatory Acne Segment Anticipated.
The global acne treatment market is stagnant in terms of incremental innovation as most players are investing in product reformulation instead of new product development. The analysts of Persistence Market Research have come up with a new publication titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025,” and have observed that the North America region is expected to witness significant growth in market revenue due to rising affinity…
